Position statement of the Spanish Association of Paediatrics-Spanish Society of Paediatric Infectious Diseases (AEP-SEIP) on the treatment of multidrug-resistant bacterial infections Documento de posicionamiento de la Asociación Española de Pediatría-Sociedad Española de Infectología Pediátrica (AEP-SEIP) sobre el tratamiento de las infecciones por bacterias multirresistentes
Aguilera Alonso, David (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM))
Escosa-García, Luis (Hospital Universitario La Paz (Madrid))
Goycochea-Valdivia, Walter Alfredo (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia))
Soler-Palacín, Pere (Hospital Universitari Vall d'Hebron)
Saavedra-Lozano, Jesús (Universidad Complutense de Madrid)
Rodrigo Gonzalo de Líria, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Cercenado, Emilia (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias)
Ramos-Amador, José-Tomás (Hospital Clínico San Carlos (Madrid))
Baquero-Artigao, Fernando (Hospital Universitario La Paz (Madrid))
Universitat Autònoma de Barcelona

Date:	2019
Abstract:	A progressive increase in the incidence of infections caused by multidrug-resistant microorganisms is being reported. Among these resistant microorganisms, the main threats are extended-spectrum β-lactamase-, AmpC-, and carbapenemase-producing Gram-negative bacilli, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. To address this important problem, it is essential to establish pediatric Antimicrobial Stewardship programs, perform active epidemiological surveillance and develop an adequate infection control policy. The therapeutic approach of these infections is often complex, frequently requiring antibiotics with less experience in children. In this position document made by the Spanish Association of Pediatrics and the Spanish Society of Pediatric Infectious Diseases, the epidemiology and treatment of these infections are reviewed according to the best available evidence.
Grants:	Instituto de Salud Carlos III CM18-00100
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Language:	Castellà
Document:	Article ; recerca ; Versió publicada
Subject:	AmpC β-lactamases ; Antimicrobial resistance ; Bacterias multirresistentes ; Carbapenemases ; Enterococcus ; Extended-spectrum β-lactamases ; Methicillin-resistant Staphylococcus aureus ; Pseudomonas aeruginosa ; Staphylococcus aureus resistente a meticilina ; β-lactamasas AmpC ; β-lactamasas de espectro extendido
Published in:	Anales de pediatría, Vol. 91 Núm. 5 (noviembre 2019) , p. 351.e1-351.e13, ISSN 1695-9531

DOI: 10.1016/j.anpedi.2019.08.002
PMID: 31635925

13 p, 451.5 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Research articles
Articles > Published articles